Amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
Amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate: 3 brands, 41 generics; first approved Feb 13, 1996; generic available.
Generic available: 41 ANDA applications approved.
Brand (NDA) products
- MYDAYISRLDTAKEDA PHARMS USANDA 02206320174 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 3.125MG;3.125MG;3.125MG;3.125MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 9.375MG;9.375MG;9.375MG;9.375MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 12.5MG;12.5MG;12.5MG;12.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 - TAKEDA PHARMS USANDA 02130320016 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ADDERALL 10RLDTEVA WOMENSNDA 01152219967 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Discontinued - 5MG;5MG;5MG;5MG TABLET ORAL Discontinued - 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Discontinued - 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Discontinued - 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Discontinued -
Generic (ANDA) products (41)
- LUPINANDA 21477720246 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ALKEM LABS LTDANDA 21778720237 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - SUN PHARM INDS INCANDA 21599720234 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 3.125MG;3.125MG;3.125MG;3.125MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 9.375MG;9.375MG;9.375MG;9.375MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 12.5MG;12.5MG;12.5MG;12.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 - SPECGX LLCANDA 21154620234 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 3.125MG;3.125MG;3.125MG;3.125MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 9.375MG;9.375MG;9.375MG;9.375MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 12.5MG;12.5MG;12.5MG;12.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 - GRANULESANDA 21702720236 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - LANNETT CO INCANDA 21556520227 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - CEDIPROF INCANDA 21075420225 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - TEVA PHARMS USAANDA 21087620224 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 3.125MG;3.125MG;3.125MG;3.125MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 9.375MG;9.375MG;9.375MG;9.375MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 12.5MG;12.5MG;12.5MG;12.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB2 - GRANULESANDA 21577120217 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - LANNETT CO INCANDA 21440320216 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ACCORD HLTHCAREANDA 21434720217 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Discontinued - 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Discontinued - 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Discontinued - 5MG;5MG;5MG;5MG TABLET ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Discontinued - - ASCENT PHARMS INCANDA 21495920216 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ASCENT PHARMS INCANDA 21370920217 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - RHODES PHARMSANDA 21311120217 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - AUROLIFE PHARMA LLCANDA 21187620206 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - ORYZAANDA 21029320206 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - ELITE LABS INCANDA 21203720196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - NESHER PHARMSANDA 21008020196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - PH HEALTHANDA 20615920196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - RHODES PHARMSANDA 21065120196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - SUN PHARM INDUSTRIESANDA 21171520196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - SPECGX LLCANDA 21154720196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ANI PHARMSANDA 20540120196 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ELITE LABS INCANDA 21135220187 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - NUVO PHARMANDA 20979920177 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - ZYDUS PHARMSANDA 20734020177 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - ALVOGENANDA 20738820177 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - IMPAX LABSANDA 07685220166 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - ACTAVIS ELIZABETHANDA 20634020167 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - COREPHARMAANDA 20672120157 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Discontinued - 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Discontinued - 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Discontinued - 5MG;5MG;5MG;5MG TABLET ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Discontinued - - AUROLIFE PHARMA LLCANDA 20242420137 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - TEVAANDA 07748820136 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - BARR LABS INCANDA 07653620136 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - ACTAVIS ELIZABETHANDA 07730220126 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 2.5MG;2.5MG;2.5MG;2.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 3.75MG;3.75MG;3.75MG;3.75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 5MG;5MG;5MG;5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 6.25MG;6.25MG;6.25MG;6.25MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 7.5MG;7.5MG;7.5MG;7.5MG CAPSULE, EXTENDED RELEASE ORAL Rx AB1 - SPECGX LLCANDA 04044020037 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - TEVA PHARMSANDA 04047220034 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Discontinued - 5MG;5MG;5MG;5MG TABLET ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Discontinued - - SUN PHARM INDUSTRIESANDA 04048020037 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB - ACTAVIS ELIZABETHANDA 04045620034 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Discontinued - 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Discontinued - 5MG;5MG;5MG;5MG TABLET ORAL Discontinued - 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Discontinued - - SANDOZANDA 04043920024 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB - EPIC PHARMA LLCANDA 04044420027 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB - BARRANDA 04042220027 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.25MG;1.25MG;1.25MG;1.25MG TABLET ORAL Rx AB 2.5MG;2.5MG;2.5MG;2.5MG TABLET ORAL Rx AB 5MG;5MG;5MG;5MG TABLET ORAL Rx AB 7.5MG;7.5MG;7.5MG;7.5MG TABLET ORAL Rx AB 1.875MG;1.875MG;1.875MG;1.875MG TABLET ORAL Rx AB 3.125MG;3.125MG;3.125MG;3.125MG TABLET ORAL Rx AB 3.75MG;3.75MG;3.75MG;3.75MG TABLET ORAL Rx AB
Patent & exclusivity timeline
Listed patents
| Patent | Expires | In | Type |
|---|---|---|---|
| 9173857 | 6 mo ago | U-2025 | |
| 8846100 | in 2 yr 10 mo | Product |
Approval history
Approvals span 1996โ2024 across 44 FDA applications.
Amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo
